These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34214206)

  • 1. AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.
    Capassoni M; Ketabchi S; Cassisa A; Caramelli R; Molinu AA; Galluccio F; Guiducci S
    J Med Virol; 2021 Oct; 93(10):5718-5720. PubMed ID: 34214206
    [No Abstract]   [Full Text] [Related]  

  • 2. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.
    Majid I; Mearaj S
    Dermatol Ther; 2021 Nov; 34(6):e15146. PubMed ID: 34590397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccine induced Sweet syndrome : a case report.
    Ben Rejeb S; Beltaifa D; Dhaoui A; Derbel F; Bellil K
    Tunis Med; 2021 Décembre; 99(12):1188-1191. PubMed ID: 35288926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech).
    Kim MJ; Kim JW; Na JI
    Dermatol Ther; 2022 Dec; 35(12):e15915. PubMed ID: 36209375
    [No Abstract]   [Full Text] [Related]  

  • 6. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.
    Žagar T; Hlača N; Brajac I; Prpić-Massari L; Peternel S; Kaštelan M
    Br J Dermatol; 2022 Mar; 186(3):e110. PubMed ID: 34817862
    [No Abstract]   [Full Text] [Related]  

  • 8. Mounting evidence suggests Sputnik COVID vaccine is safe and effective.
    Nogrady B
    Nature; 2021 Jul; 595(7867):339-340. PubMed ID: 34230663
    [No Abstract]   [Full Text] [Related]  

  • 9. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
    Shakir S; Lane S; Davies M
    Drug Saf; 2021 Jan; 44(1):1-5. PubMed ID: 33219926
    [No Abstract]   [Full Text] [Related]  

  • 10. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.
    Casucci G; Acanfora D
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 12. A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2021 Jan; 21(1):2-3. PubMed ID: 33069282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Temporary suspension of AstraZeneca's vaccine; a reconstruction].
    Maas DPMSM; Kramers C; Smit HJCA; Middeldorp S; Helsloot I
    Ned Tijdschr Geneeskd; 2021 Apr; 165():. PubMed ID: 33914428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.
    Suvvari TK; Rajesh E; D Silva RG; Corriero AC; Kutikuppala LVS
    J Med Virol; 2021 Oct; 93(10):5721-5723. PubMed ID: 34232526
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event.
    Fan BE; Shen JY; Lim XR; Tu TM; Chang CCR; Khin HSW; Koh JS; Rao JP; Lau SL; Tan GB; Chia YW; Tay KY; Hameed S; Umapathi T; Ong KH; Prasad BMRV
    Am J Hematol; 2021 Sep; 96(9):E357-E361. PubMed ID: 34133027
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
    Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
    Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.